Trial Profile
Calcipotriol Plus Hydrocortisone in Paediatric Patients (Aged 6 to 17 Years) With Psoriasis Vulgaris on the Face and on the Intertriginous Areas
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Oct 2021
Price :
$35
*
At a glance
- Drugs Calcipotriol/hydrocortisone (Primary) ; Hydrocortisone (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- 03 Jul 2012 Additional trial location (Germany) added as reported by European Clinical Trials Database record.
- 06 Dec 2010 Actual end date (Dec 2010) added as reported by ClinicalTrials.gov.
- 06 Dec 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.